Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR183 | P32249 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5101761 | 1.00 | GPR183 (0.38) | GPR183KCNH2ALDH1A1SMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL5102040 | 0.99 | KCNH2 (0.38) | GPR183KCNH2ALDH1A1SMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL5102044 | 0.99 | KCNH2 (0.38) | GPR183KCNH2ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL5098172 | 0.87 | GSK3B (0.41) | ALDH1A1SMN1; SMN2KDM4EGSK3BMCHR1 | |
| SCHEMBL5101560 | 0.87 | GPR183 (0.41) | GPR183KCNH2SMN1; SMN2GSK3B | |
| SCHEMBL5101563 | 0.87 | GPR183 (0.41) | GPR183KCNH2SMN1; SMN2GSK3B | |
| SCHEMBL5098233 | 0.84 | GSK3B (0.38) | ALDH1A1SMN1; SMN2TSHRKDM4EGSK3B | |
| SCHEMBL1924617 | 0.83 | ALDH1A1 (0.35) | GPR183ALDH1A1SMN1; SMN2TSHRKDM4E | |
| SCHEMBL1924618 | 0.83 | ALDH1A1 (0.35) | GPR183ALDH1A1SMN1; SMN2TSHRKDM4E | |
| SCHEMBL5107832 | 0.83 | GPR183 (0.36) | GPR183KCNH2GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7314877-B2 | Benzofuran derivative | KOWA CO., LTD. (JP) | 2008-01-01 | — | — | US | claimed |
| US-20060189621-A1 | Benzofuran derivative | KOWA CO., LTD. (JP) | 2006-08-24 | — | — | US | claimed |
| EP-1602655-A1 | BENZOFURAN DERIVATIVE | Kowa Co., Ltd. (JP) | 2005-12-07 | — | — | EP | claimed |
| US-7314877-B2 | Benzofuran derivative | KOWA CO., LTD. (JP) | 2008-01-01 | — | — | US | disclosed |
| US-20060189621-A1 | Benzofuran derivative | KOWA CO., LTD. (JP) | 2006-08-24 | — | — | US | disclosed |
| EP-1602655-A1 | BENZOFURAN DERIVATIVE | Kowa Co., Ltd. (JP) | 2005-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060189621-A1 | Benzofuran derivative | TNF, TNFRSF1A, RELA | GPR183 1025/4885KCNH2 3368/4885ALDH1A1 171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.